US-China chip rivalry
Scope
Date
~
-
Bio & Pharma
Celltrion's Truxima shows safety, efficacy in post-marketing study
South Korean biopharmaceutical company Celltrion Inc. reported on Wednesday that its biosimilar drug Truxima (rituximab), a generic version of Roche...
Feb 16, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Biopharm holds sales meeting for marketing Cenobamate in US
On Wednesday, SK Biopharmaceuticals Co. announced that its US subsidiary, SK Life Sciences Inc., held a "National Sales Meeting" in San Diego. The p...
Feb 16, 2023 (Gmt+09:00)
-
Batteries
Ford EV production halt casts doubts over SK cell quality
Ford Motor Co. said on Tuesday it has stopped production and shipments of the F-150 Lightning electric pickup truck due to a possible battery issue,...
Feb 15, 2023 (Gmt+09:00)
-
Perspectives
Biden must ensure US allies aren’t China collateral damage
The biggest irony about China-US relations today is just how much Xi Jinping misses Donald Trump. China’s leader would never admit this. ...
Feb 15, 2023 (Gmt+09:00)
-
Business & Politics
Korean Chips Act revision hits roadblock as opposition lawmakers balk
The proposed revision to South Korea’s answer to the US CHIPS and Science Act has hit a roadblock as the main opposition party, which controls...
Feb 15, 2023 (Gmt+09:00)
-
Batteries
POSCO ties up with Aussie firm on US EV cell mineral project
South Korea’s POSCO Group has joined hands with an Australian company to work on an electric vehicle battery material project in the US as it ...
Feb 14, 2023 (Gmt+09:00)
-
Batteries
LG Energy Solution tops global EV battery market excluding China
South Korea's LG Energy Solution Ltd. for the second straight year was No. 1 on the global market for electric vehicle (EV) batteries excluding Chin...
Feb 14, 2023 (Gmt+09:00)
-
Korean stock market
KB Securities launches AI-based RoboNews on US stocks
South Korea's KB Securities announced the launch of KB RoboNews on Monday, a cutting-edge artificial intelligence (AI) service that provides insight...
Feb 14, 2023 (Gmt+09:00)
-
Automobiles
Hyundai Motor offers Bluelink free to new customers in US
Hyundai Motor Co. in a world first is offering lifetime membership of its connected car care service Bluelink free to new customers in the US, judgi...
Feb 14, 2023 (Gmt+09:00)
-
Artificial intelligence
S.Korean IT firms rush for tie-ups to compete with ChatGPT
South Korean tech companies are rushing to form partnerships in different sectors to develop superior AI services to compete with ChatGPT, a chatbot...
Feb 13, 2023 (Gmt+09:00)
-
Artificial intelligence
S.Korean AI chip developer Rebellions releases Atom SoC
South Korean AI chip developer Rebellions Inc. announced on Monday the release of its AI chip Atom, a system-on-chip (SoC) designed for data centers...
Feb 13, 2023 (Gmt+09:00)
-
Automobiles
Hyundai's cumulative EV sales in US surpass 100,000
Hyundai Motor Group has achieved over 100,000 cumulative electric vehicle (EV) sales in the US market since 2014. The group's three brands, Hyundai,...
Feb 13, 2023 (Gmt+09:00)
-
Cloud computing
Hancom goes global with SDK, SaaS products
South Korea’s homegrown office suite developer Hancom Inc. will seek to boost its brand awareness in the global B2B software market with softw...
Feb 10, 2023 (Gmt+09:00)
-
Automobiles
Hyundai Motor Group ranks first in US vehicle dependability study
Hyundai Motor Group has once again topped the U.S. Vehicle Dependability Study (VDS) conducted by J.D. Power, ranking first among 16 global automoti...
Feb 10, 2023 (Gmt+09:00)
-
The Deep Dive
S.Korea’s love of luxury ushers in 3rd wave of bling boom
Global luxury brands from Louis Vuitton to Chanel and Thom Browne are readying themselves for a third wave of the luxury boom in South Korea, where ...
Feb 09, 2023 (Gmt+09:00)
-
Bio & Pharma
HLB’s Rivoceranib, Hengrui's Camrelizumab approved as combination therapy in China
South Korea's HLB Co. announced on Thursday that the combination therapy of its drug candidate rivoceranib and Jiangsu Hengrui Pharmaceuticals Co., ...
Feb 09, 2023 (Gmt+09:00)
-
Batteries
Korea EV battery makers lose market share against Chinese rivals
South Korean electric vehicle cell makers lost a market share against Chinese competitors last year as they failed to fully benefit from a surge in ...
Feb 08, 2023 (Gmt+09:00)
-
Automobiles
Hyundai's IONIQ 5 named Best Electric Vehicle of 2023 in US
Cars.com, a US automobile evaluation website, named the Hyundai Motor Co.'s IONIQ 5 as the Best Electric Vehicle of 2023 on Tuesday. According to Hy...
Feb 08, 2023 (Gmt+09:00)
-
Bio & Pharma
Medytox to sell off 2.2 mn shares of Daewoong's American partner Evolus
Medytox Inc. said in a regulatory filing on Wednesday that it is selling off approximately 2.19 million shares of Evolus, Daewoong Pharmaceutical's ...
Feb 08, 2023 (Gmt+09:00)
-
Companies
China's alleged Korean trademark piracy surges during COVID-19
South Korean companies have witnessed a sharp increase in alleged trademark piracy in China over the past few years, as COVID-19 curbed their overse...
Feb 07, 2023 (Gmt+09:00)
-
Earnings
SKC eyes M&As in semiconductor, rechargeable battery materials
SKC Inc., a South Korean chemical materials company under SK Group, is seeking to buy semiconductor and rechargeable battery materials companies in ...
Feb 06, 2023 (Gmt+09:00)
-
Foreign exchange
Korean won falls on firm US jobs data, new BOJ head report
The South Korean won currency skidded to a four-week low on Monday as stronger-than-expected US employment data renewed expectations that the Federa...
Feb 06, 2023 (Gmt+09:00)
-
Corporate investment
S.Korea's high-tech firms flood to US with heavy spending plans
South Korea’s large business groups are flooding to the US, with their pledged investments there exceeding $100 billion for the next two years...
Feb 06, 2023 (Gmt+09:00)
-
Automobiles
Hyundai GV70 EV to be eligible for US subsidy after classification as SUV
The sport-utility vehicle (SUV) Hyundai Genesis GV70 electric vehicle in the first half of the year is expected to be eligible for subsidies in the ...
Feb 06, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
NCSOFT lays off 20% of US operation before new game release
NCSOFT Corp., South Korea’s major game developing and publishing company, has recently laid off about 20% of its North American operation, joi...
Feb 03, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma's botulinum toxin Nabota proves long-lasting effect
Daewoong Pharmaceutical said on Friday that a high-dose administration of botulinum toxin Nabota (US brand name: Jeuveau) to patients with frown wri...
Feb 03, 2023 (Gmt+09:00)
-
Business & Politics
Korea’s new EV subsidy plan favors Hyundai over Tesla, other imports
South Korea is revising its electric vehicle subsidy plan in a way that favors local cars such as the Hyundai IONIQ 6 over imported vehicles, includ...
Feb 03, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
MBK, Unison to expand Osstem Implant's target reach beyond China
South Korean private equity firm Unison Capital Korea is set to focus on boosting the corporate value of Osstem Implant Co., once the PE manager and...
Feb 03, 2023 (Gmt+09:00)
-
Automobiles
Hyundai, Kia post record-high Jan. sales figures in US
Hyundai Motor Co. and Kia Corp. posted the highest sales record in the US market in January. Hyundai Motor America said on Wednesday that it sold 52...
Feb 02, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi's Rolvedon set to post $10 mn in Q4 net sales in US
South Korean drugmaker Hanmi Pharmaceutical Co.’s neutropenia agent, Rolvedon (eflapegrastim-xnst), is forecast to achieve about $10 million i...
Feb 02, 2023 (Gmt+09:00)